Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma

NCT02853370

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Créteil (Hôpital Henri Mondor) Créteil, France
  • Dijon (CHU de Dijon - Hôpital d'Enfants) Dijon, France
  • Grenoble cedex 9 (CHU Michallon) Grenoble, France
  • Le Kremlin Bicêtre (Hôpital Bicêtre) Le Kremlin-Bicêtre, France
View all 30 locations
View Trial Details
Completed

Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL

NCT04030195

Conditions
B-cell Chronic Lymphocytic Leukemia, B-cell Non Hodgkin Lymphoma, Chronic Disease, +25 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Columbia University New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Selinexor Treatment of Refractory Myeloma

NCT02336815

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic (AZ) Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • Jonnsson Comprehensive Cancer Center / University of Los Angeles Los Angeles, California, United States
View all 61 locations
View Trial Details

Related conditions